Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

734.81
-23.4600-3.09%
Pre-market: 741.977.16+0.97%08:54 EDT
Volume:1.04M
Turnover:770.25M
Market Cap:75.65B
PE:18.17
High:777.43
Open:766.53
Low:726.02
Close:758.27
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.30
T/O Rate:1.05%
Dividend:3.64
Dividend Rate:0.50%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.39
PE(LYR):17.71

Loading ...

Regeneron Pharmaceuticals, - Plans Phase 2 Trial of Trevogrumab with Glp-1 Therapies in Older Adults

THOMSON REUTERS
·
Yesterday

Phase 2 Courage Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During Glp-1 Receptor Agonist-Induced Weight Loss

THOMSON REUTERS
·
Yesterday

Regeneron Pharmaceuticals, - Trevogrumab Prevents 70% of Muscle Loss Associated with Semaglutide Treatment

THOMSON REUTERS
·
Yesterday

Movement Alert|Regeneron Pharmaceuticals Falls 3.08% in Regular Trading, Expanded Sanofi Alliance Fails to Meet Investor Expectations on Deal Terms

Market Focus
·
Yesterday

Regeneron Exec Says Co Eligible to Receive $1 Bln in Potential Milestone Payment with the Start of the First Late-Stage Trial as Part of the Deal -Conf Call

THOMSON REUTERS
·
Yesterday

Regeneron Exec Says Co Expects to Start Pivotal Study for Regn20423 Either in Late 2027 or Early 2028

THOMSON REUTERS
·
Yesterday

Regeneron Pharma Price Target Announced at $850.00/Share by Argus Research

Dow Jones
·
Yesterday

Sanofi Exec Says "There is no Certainty at This Point in Time, but We are Actively Working in Order to Extend the Loss of Exclusivity of Dupixent"

THOMSON REUTERS
·
Yesterday

Sanofi CEO Says Expects the Market for Atopic Dermatitis Treatments to Nearly Double over the Next Five Years -Conf Call

THOMSON REUTERS
·
Yesterday

Argus Upgrades Regeneron Pharmaceuticals to Buy From Hold, Price Target is $850

MT Newswires Live
·
Yesterday

Regeneron Pharmaceuticals, Inc. : Argus Research Raises to Buy from Hold

THOMSON REUTERS
·
Yesterday

Stocks to Watch: Micron, Alphabet, Sanofi, Nu Holdings

Dow Jones
·
Yesterday

Sanofi’s Regeneron Fix Requires Extra Shot of M&A

Reuters
·
Yesterday

Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook

Dow Jones
·
Yesterday

Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance

Dow Jones
·
Yesterday

Sanofi, Regeneron Expand Tie-up with $8 Billion Drug-Development Deal, Settle Legal Dispute

Reuters
·
Yesterday

Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment

Reuters
·
Yesterday

Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront

Reuters
·
Yesterday

Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits

THOMSON REUTERS
·
Yesterday

Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation

THOMSON REUTERS
·
Yesterday